Finally got to read the report. So yes, there are 12 patients. Before, I posted based on memory. Even with this report, it does not mention what happened to the other 2 patients. I know the other 2 patients was never mentioned at all during the update announcement so that is why I assume only 2 patients in Cohort 1.
Onwards and upwards indeed. Especially for these patients who are still around. Hopefully the combo trial will bring about better results. Or maybe they can stick around long enough for CF33 to come over and blast away any residual cancer
Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT, page-30
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |